Gene interactions and pathways from curated databases and text-mining

◀ Back to FOS

CPOX — FOS

Text-mined interactions from Literome

Granet et al., Cell Signal 2002 : Downregulation of protein kinase C ( PKC ) and COX1/2 or inhibition of ERK1/2, p38 ( MAPK ) or src kinases had no major effect on AP-1 mRNA expression in the Flexcell
Tomita et al., Respirology 2002 : Using a human airway cell line ( LC-2/ad ), lipopolysaccharide (LPS) induced gene expression of hBD-2 was studied in the absence or the presence of ( i ) dexamethasone, ( ii ) inhibition of NF-kappaB and AP-1 , ( iii ) intracellular calcium chelator, and ( iv ) cyclooxygenase (COX) inhibitors ... These findings suggest that glucocorticoids ( GC ), but not COX inhibitors, reduce hBD-2 gene expression, while NF-kappaB, AP-1 and intracellular calcium are essential for hBD-2 expression
Konsman et al., J Comp Neurol 2004 (Inflammation) : Furthermore, although COX inhibitors attenuate expression of the activation marker c-Fos in the preoptic and paraventricular hypothalamus after administration of IL-1 beta or bacterial lipopolysaccharide (LPS), they do not alter c-Fos induction in other structures known to express prostaglandin receptors
Hwang et al., J Biol Chem 2005 : Here, we investigated the role of c-Jun and activator protein-1 (AP-1) in IL-1beta induced dedifferentiation and cyclooxygenase (COX)-2 expression in primary cultured chondrocytes
Uenoyama et al., Oncogene 2006 (Anoxia...) : Furthermore, COX-2 expression was also reduced by the inhibition of transcription factor AP-1
Lee et al., J Biomed Sci 2008 (Colitis...) : In addition, consumption of UDN glycoprotein attenuated the activities of proliferating cell nuclear antigen ( PCNA ), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) , and inhibited the DNA binding activities of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) in the mice colonic tissue
Lee et al., Anesth Analg 2008 (Hyperalgesia...) : We examined the role of intrathecal selective and nonspecific COX inhibitors on spinal C-Fos expression